A new, retrospective study trying to tease out the benefits of MitraClip procedures according to the etiology of mitral regurgitation (MR) hints that, compared with conservative management, ...

Patients with secondary mitral regurgitation (MR) who were left with high gradients after a MitraClip procedure were not inherently at a disadvantage in their subsequent clinical outcomes, according ...

Transcatheter edge-to-edge repair (TEER) with the MitraClip (Abbott) to treat functional and degenerative mitral regurgitation (MR) fails relatively infrequently when performed at high-volume centers, ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved outcomes and symptoms in patients with moderate to severe mitral ...

Abbott Vascular has announced today that its first-in-class, catheter-based MitraClip device has been approved by the FDA for the treatment of patients with mitral regurgitation. Perspective from ...

SAN DIEGO -- Percutaneous repair of the mitral valve improved key outcomes in moderate-to-severe, symptomatic mitral regurgitation for heart failure patients who had exhausted pharmaceutical options, ...

The MitraClip is implanted in a percutaneous procedure that is performed using both fluoroscopic and echocardiographic guidance. First, femoral venous access is obtained via standard percutaneous ...

In 2013, the FDA approved an implantable device to treat leaky heart valves. Among its inventors was Mehmet Oz, the former television personality and former U.S. Senate candidate widely known as "Dr.

A study from Abbott found that employing its cardiac valve repair implant during earlier phases of heart failure—when a patient’s leaky mitral valve is still considered to be functional—could lead to ...

The US Food and Drug Administration (FDA) has approved what is now the third generation of the MitraClip system for transcatheter-based mitral valve repair, Abbott Vascular announced in a news release ...

A seemingly simple but sophisticated clip may usher in a “new era” for patients suffering from a severe and difficult-to-treat complication of heart failure, according to a new study. The device, ...